Brief: Isofol: Arfolitixorin Gets Additional Clinical Patent Approval In US

Isofol Medical AB (publ)

05/05/2020 06:51

May 5 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * ISOFOL'S DRUG CANDIDATE ARFOLITIXORIN RECEIVES ADDITIONAL
CLINICAL PATENT APPROVAL IN THE UNITED STATES
    * TODAY ANNOUNCED APPROVAL OF A CLINICAL PATENT FOR
ARFOLITIXORIN
IN UNITED STATES
    * PATENT EXPIRES IN 2038 AND IS A DIVISIONAL PATENT FOR
MASTER
PATENT GRANTED IN US IN MAY 2019
    * NOW GRANTED PATENT (US 10,639,311) IS MORE SPECIFICALLY
FOCUSED
ON DOSE REGIMEN USED IN ONGOING CLINICAL AGENT STUDY

Source text for Eikon:  ID:nWkrJP7gp 
Further company coverage:  ISOFOL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))